E-LIB Suche - Ergebnisse für: Coart, Elisabeth

1

Minimization in randomized clinical trials:

Coart, Elisabeth ; Bamps, Perrine ; Quinaux, Emmanuel...
Statistics in Medicine. 42 (2023) 28 - p. 5285-5311 , 2023

Link: https://doi.org/10.1002/..

2

Trial Design for Cancer Immunotherapy: A Methodological Too..:

Saad, Everardo D. ; Coart, Elisabeth ; Deltuvaite-Thomas, Vaiva...
Cancers. 15 (2023) 18 - p. 4669 , 2023

Link: https://doi.org/10.3390/..

3

The case against censoring of progression-free survival in ..:

Jamoul, Corinne ; Collette, Laurence ; Coart, Elisabeth...
BMC Medical Research Methodology. 22 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

4

Clinical Trial Endpoints in Metastatic Cancer: Using Indivi..:

Goldberg, Richard M ; Adams, Richard ; Buyse, Marc...
JNCI: Journal of the National Cancer Institute. 114 (2021) 6 - p. 819-828 , 2021

Link: https://doi.org/10.1093/..

5

Evaluating the potential of relapse-free survival as a surr..:

Coart, Elisabeth ; Suciu, Stefan ; Squifflet, Pierre...
European Journal of Cancer. 137 (2020) - p. 171-174 , 2020

Link: https://doi.org/10.1016/..

6

MPN-147: Dynamic and Time-To-Event Analyses Demonstrate Mar..:

McLornan, Donal ; Mesa, Ruben ; Catalano, John...
Clinical Lymphoma Myeloma and Leukemia. 20 (2020) - p. S329-S330 , 2020

Link: https://doi.org/10.1016/..

7

The impact of data errors on the outcome of randomized clin..:

Buyse, Marc ; Squifflet, Pierre ; Coart, Elisabeth...
Clinical Trials. 14 (2017) 5 - p. 499-506 , 2017

Link: https://doi.org/10.1177/..

8

Understanding and Communicating Measures of Treatment Effec..:

Saad, Everardo D ; Zalcberg, John R ; Péron, Julien...
JNCI: Journal of the National Cancer Institute. 110 (2017) 3 - p. 232-240 , 2017

Link: https://doi.org/10.1093/..

9

Protein Kinase Activity Decreases with Higher Braak Stages ..:

Rosenberger, Andrea F.N. ; Hilhorst, Riet ; Coart, Elisabeth...
Journal of Alzheimer's Disease. 49 (2016) 4 - p. 927-943 , 2016

Link: https://doi.org/10.3233/..

10

Minimization in randomized clinical trials:

Coart, Elisabeth ; Bamps, Perrine ; Quinaux, Emmanuel...
STATISTICS IN MEDICINE, 42 (28) , p. 5285 -5311. , 2024

Link: http://hdl.handle.net/19..

11

Trial Design for Cancer Immunotherapy: A Methodological Too..:

Saad, Everardo D ; Coart, Elisabeth ; DELTUVAITE-THOMAS, Vaiva...
CANCERS, 15 (18) (Art N° 4669). , 2023

Link: http://hdl.handle.net/19..

12

The case against censoring of progression-free survival in ..:

Jamoul, Corinne ; Collette, Laurence ; Coart, Elisabeth...
BMC Medical Research Methodology, 22 (1) (Art N° 260). , 2023

Link: http://hdl.handle.net/19..

13

Trial Design for Cancer Immunotherapy: A Methodological Too..:

Saad, Everardo D ; Coart, Elisabeth ; Deltuvaite-Thomas, Vaiva...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527464/. , 2023

Link: http://www.ncbi.nlm.nih...

14

The case against censoring of progression-free survival in ..:

Jamoul, Corinne ; Collette, Laurence ; Coart, Elisabeth...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532825/. , 2022

Link: http://www.ncbi.nlm.nih...

15

Evaluation of Continuous Tumor-Size–Based End Points as Sur..:

Burzykowski, Tomasz ; Coart, Elisabeth ; Saad, Everardo D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755539/. , 2019

Link: http://www.ncbi.nlm.nih...